Sarah B. Noonberg Insider Trading $NLTX Neoleukin Therapeutics, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Sarah B. Noonberg.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Sarah B. Noonberg. Sarah B. Noonberg is Director in Protagonist Therapeutics, Inc ($PTGX) and Director in Neoleukin Therapeutics, Inc. ($AQXP) and Chief Medical Officer in Prothena Corp plc ($PRTA).

Sarah B. Noonberg in Neoleukin Therapeutics, Inc.

Trading Symbol: NLTX
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Sarah B. Noonberg: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 13 2021
$NLTX Market Capitalization: $451.60M
$NLTX Previous Close: $18.81

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Sarah B. Noonberg in Neoleukin Therapeutics, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, NLTX, PTGX, PRTA

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares
May 13 2021	NLTX	Neoleukin Therapeu ...	Noonberg Sarah B.	Director	Option Exercise	A	11.40	25,000	285,000	25,000
May 07 2020	NLTX	Neoleukin Therapeu ...	Noonberg Sarah B.	Director	Option Exercise	A	12.84	25,000	321,000	25,000
Oct 15 2019	AQXP	Neoleukin Therapeu ...	Noonberg Sarah B.	Director	Option Exercise	A	2.82	22,000	62,040	22,000
Oct 15 2019	AQXP	Neoleukin Therapeu ...	Noonberg Sarah B.	Director	Option Exercise	A	2.82	22,000	62,040	22,000

Page: 1